Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma-Reference-Cited by-同舟云学术

Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma

Published:2021-04-05 Issue:7 Volume:26 Page:1188-1195
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Motai Risa,Sawabe Michi,Kadowaki Shigenori,Sasaki Eiichi,Nishikawa Daisuke,Suzuki Hidenori,Beppu Shintaro,Terada Hoshino,Hanai Nobuhiro^ORCID

Funder

Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports, Culture and Technology of Japan

Health Labour Sciences Research Grant

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

https://link.springer.com/content/pdf/10.1007/s10147-021-01907-x.pdf

Reference21 articles.

1. Ferlay J et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917

2. Adelstein DJ et al (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21(1):92–98

3. Forastiere AA et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098

4. Emami B et al (1987) Reirradiation of recurrent head and neck cancers. Laryngoscope 97(1):85–88

5. Temam S et al (2005) Salvage surgery after failure of very accelerated radiotherapy in advanced head-and-neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 62(4):1078–1083

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subsequent chemotherapy with paclitaxel plus cetuximab-based chemotherapy following immune checkpoint inhibitor in recurrent or metastatic squamous cell carcinoma of the head and neck;Frontiers in Oncology;2023-11-21

2. Association between human papillomavirus and oral cancer: a literature review;International Journal of Clinical Oncology;2023-03-17

3. Both combined or sequential use with immune checkpoint inhibitors on cetuximab-treated patients with recurrent or metastatic head and neck squamous cell carcinoma improve the overall survival;Oral Oncology;2021-08